DE69930862D1 - Expressionssysteme zur funktionellen expression von nukleinsäuren - Google Patents

Expressionssysteme zur funktionellen expression von nukleinsäuren

Info

Publication number
DE69930862D1
DE69930862D1 DE69930862T DE69930862T DE69930862D1 DE 69930862 D1 DE69930862 D1 DE 69930862D1 DE 69930862 T DE69930862 T DE 69930862T DE 69930862 T DE69930862 T DE 69930862T DE 69930862 D1 DE69930862 D1 DE 69930862D1
Authority
DE
Germany
Prior art keywords
expression
nucleic acids
functional
systems
expression systems
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69930862T
Other languages
English (en)
Other versions
DE69930862T2 (de
Inventor
Kazunari Taira
Jun Ohkawa
Shiori Koseki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Institute of Advanced Industrial Science and Technology AIST
Original Assignee
National Institute of Advanced Industrial Science and Technology AIST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Institute of Advanced Industrial Science and Technology AIST filed Critical National Institute of Advanced Industrial Science and Technology AIST
Application granted granted Critical
Publication of DE69930862D1 publication Critical patent/DE69930862D1/de
Publication of DE69930862T2 publication Critical patent/DE69930862T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C12N2310/121—Hammerhead
DE69930862T 1998-08-31 1999-08-31 Expressionssysteme zur funktionellen expression von nukleinsäuren Expired - Lifetime DE69930862T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP24475598 1998-08-31
JP10244755A JP2990268B1 (ja) 1998-08-31 1998-08-31 機能性核酸転写用発現系
PCT/JP1999/004718 WO2000012686A1 (en) 1998-08-31 1999-08-31 Expression systems for functional nucleic acid expression

Publications (2)

Publication Number Publication Date
DE69930862D1 true DE69930862D1 (de) 2006-05-24
DE69930862T2 DE69930862T2 (de) 2007-05-16

Family

ID=17123425

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69930862T Expired - Lifetime DE69930862T2 (de) 1998-08-31 1999-08-31 Expressionssysteme zur funktionellen expression von nukleinsäuren

Country Status (5)

Country Link
US (2) US6740750B1 (de)
EP (1) EP1118659B1 (de)
JP (2) JP2990268B1 (de)
DE (1) DE69930862T2 (de)
WO (1) WO2000012686A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995258B1 (en) 2000-05-25 2006-02-07 City Of Hope Nucleolar targeting of therapeutics against HIV
AU2003237303A1 (en) * 2002-05-30 2003-12-19 Albert Einstein College Of Medicine Of Yeshiva University Aptamer constructs
AU2004208057A1 (en) * 2003-01-31 2004-08-12 Dnavec Research Inc. Paramyxovirus vector encoding ribozyme and utilization thereof
ATE459707T1 (de) * 2003-06-30 2010-03-15 Dnavec Research Inc Negativ-strang rna-virus-vektoren, welche ein gen mit veränderten hypermutierbaren regionen tragen
US20050203047A1 (en) * 2004-03-10 2005-09-15 Ulrich Thomann Delivery vectors for short interfering RNA, micro-RNA and antisense RNA

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792608A (en) * 1991-12-12 1998-08-11 Gilead Sciences, Inc. Nuclease stable and binding competent oligomers and methods for their use
DE69333937T2 (de) 1992-06-29 2006-08-31 Gene Shears Pty. Ltd. Nukleinsäuren und sie verwendende verfahren zur bekämpfung viraler pathogene
WO1994008033A1 (en) * 1992-10-02 1994-04-14 The Board Of Trustees Of The Leland Stanford Junior University tRNA GENES TO STABILIZE UNSTABLE PLASMID INHERITANCE IN GROWING CELLS
EP0702716A4 (de) 1993-05-17 1999-05-26 Univ California Gentherapy bei hiv-infektion und aids mit hilfe von ribozymen
DE69535752D1 (de) * 1994-04-13 2008-06-26 Biotransplant Inc Alpha(1,3)galactosyltransferase-negatives schwein
US20020058636A1 (en) * 1994-09-21 2002-05-16 Geoffrey P. Symonds Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
US6132989A (en) * 1996-06-03 2000-10-17 University Of Washington Methods and compositions for enhanced stability of non-adenoviral DNA

Also Published As

Publication number Publication date
JP3829176B2 (ja) 2006-10-04
EP1118659A1 (de) 2001-07-25
US20040198689A1 (en) 2004-10-07
DE69930862T2 (de) 2007-05-16
EP1118659B1 (de) 2006-04-12
WO2000012686A1 (en) 2000-03-09
EP1118659A4 (de) 2002-12-04
JP2990268B1 (ja) 1999-12-13
JP2000069972A (ja) 2000-03-07
US6740750B1 (en) 2004-05-25

Similar Documents

Publication Publication Date Title
DE69829526D1 (de) System zur Detektion von Zügen
DE69929099D1 (de) Gerät zur Extraktion von Nukleinsäuren
DE69739128D1 (de) Invasive Spaltung von Nukleinsäuren
DE69915932D1 (de) Verfahren zur Bestimmung von Ziel-Nukleinsäuren
DE59912604D1 (de) Verfahren zur isolierung und aufreinigung von nucleinsäuren
DE69807962T2 (de) Verfahren zur Reinigung von rohem 1,1,1,3,3-Pentafluorpropan
DE60033236D1 (de) System zur vermeidung von heckcrashs bei flugzeugen
DE69835676D1 (de) Dna polymerase-verwandte faktoren
DE59804785D1 (de) Verbessertes Verfahren zur Stabilisierung von Proteinen
DE69921311D1 (de) Vervielfältigung von nukleinsäuren
DE59712415D1 (de) Verfahren zur amplifikation von nukleinsäure
DE59809733D1 (de) Hbv-gerichtete antisense-nukleinsäuren
IS4629A (is) Samskeyttar veirukjarnsýrur
DE69930862D1 (de) Expressionssysteme zur funktionellen expression von nukleinsäuren
DE59902633D1 (de) Verfahren zur Umesterung von Alpha-Ketocarbonsäuren
DE69807148D1 (de) Verfahren zur Hydroformylierung von Olefininen
DE29722473U1 (de) Trenneinrichtung zur Trennung von Substanzen
DE69834799D1 (de) Vorrichtung zur Bewegungseinschränkung von Lasten
DE69919104D1 (de) Verfahren zur Spurverfolgungsregelung
DE69800114T2 (de) Verfahren zur Hydrierung von Cyanopropanaldehyden enthaltend Cyanopropionaldehydacetalen
DE69721264D1 (de) Verfahren zur Darstellung von Polyestercarbonaten
DE29714382U1 (de) Vorrichtung zur drahtlosen Betätigung von Anlagen
DE59808864D1 (de) System zur Ermittlung des Nährstoffbedarfes
DE69719726T2 (de) Verfahren zur Detektion von Leukämie
DE29719818U1 (de) Vorrichtung zur Beschichtung von Kathetern

Legal Events

Date Code Title Description
8364 No opposition during term of opposition